| Frontiers in Genetics | 卷:12 |
| Role of Nanotechnology and Their Perspectives in the Treatment of Kidney Diseases | |
| Xiaogang Li1  J. P. Jose Merlin2  | |
| [1] Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, United States; | |
| [2] Department of Internal Medicine, Mayo Clinic, Rochester, MN, United States; | |
| 关键词: nanotechnology; nanoparticles; nanomedicine; drug delivery; kidney disease; | |
| DOI : 10.3389/fgene.2021.817974 | |
| 来源: DOAJ | |
【 摘 要 】
Nanoparticles (NPs) are differing in particle size, charge, shape, and compatibility of targeting ligands, which are linked to improved pharmacologic characteristics, targetability, and bioavailability. Researchers are now tasked with developing a solution for enhanced renal treatment that is free of side effects and delivers the medicine to the active spot. A growing number of nano-based medication delivery devices are being used to treat renal disorders. Kidney disease management and treatment are currently causing a substantial global burden. Renal problems are multistep processes involving the accumulation of a wide range of molecular and genetic alterations that have been related to a variety of kidney diseases. Renal filtration is a key channel for drug elimination in the kidney, as well as a burgeoning topic of nanomedicine. Although the use of nanotechnology in the treatment of renal illnesses is still in its early phases, it offers a lot of potentials. In this review, we summarized the properties of the kidney and characteristics of drug delivery systems, which affect a drug’s ability should focus on the kidney and highlight the possibilities, problems, and opportunities.
【 授权许可】
Unknown